Gilat Satellite: Risks Are Mounting, But Valuation Is Too Cheap To Ignore

Upgrade from Hold to Buy. The selloff has moved faster than the business has deteriorated. The risk/reward now favors the buyer.

Gilat Satellite Networks (NASDAQ: GILT) has been savaged by the market. The stock trades around $11.23, roughly 45% below its 52-week high of $20.93. A 21% plunge followed Q1 earnings in May, despite an EPS beat. Q2 came out last week with another modest EPS beat and shares fell 5% the next day. The pattern is exhausting for holders: solid results, punished stock.

The question this setup demands is whether the business is actually breaking, or whether the multiple has detached from the fundamentals. The Q2 report tips the answer. Growth is intact, margins are expanding, a transformative acquisition is on track, and the valuation has reset to levels that would have looked cheap even before this selloff.

What the Q2 numbers actually show

Revenue hit $122.7 million, up 17% year-over-year. Depending on which consensus estimate you track, it was a hair above or a hair below. Either way, it's not the kind of miss that destroys a growth story. Adjusted EPS of $0.20 beat the consensus range of $0.14 to $0.16. GAAP EPS of $0.10 was in line.

The margin expansion is the more important signal. Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization — a rough cash-earnings proxy that strips out non-cash charges) rose 31% year-over-year to $15.4 million, pushing the adjusted EBITDA margin from 11.2% to 12.6%. On a $122.7 million revenue base, a 1.4-percentage-point margin improvement means the company is generating meaningfully more operating cash per dollar of sales.

GAAP operating income of $4.7 million was below last year's $5.7 million, and GAAP net income fell to $8.1 million from $9.8 million. That's the stock's chronic problem: GAAP results don't look dramatic because of timing-related inventory costs, depreciation, and amortization. But investors tracking Gilat for two quarters now should know this distinction. The adjusted numbers tell the operating story; the GAAP numbers tell an accounting story.

Three engines, all running

Commercial revenue grew 20% to $83 million, driven by in-flight connectivity. Gilat delivered more than 200 terminals in the quarter — a record. The company has just over 600 Sidewinder terminals operating today, with $43 million in fresh orders from a leading IFC provider. Boeing line-fit certification is advancing, with first-unit deliveries expected in Q4. An Airbus agreement broadened the opportunity, though it didn't trigger a Stellar Blu earn-out payment. The installed base is growing; the question is how fast airlines cycle aircraft through maintenance, which is outside Gilat's control.

Defense revenue rose 12% to $22.5 million. More importantly, management said defense revenue is expected to be "materially higher" in the second half, with H2 growth projected around 40% versus H1. New orders include $11 million from the U.S. Department of Defense and a multi-million-dollar order from a European defense ministry. The Viper Ka terminal, designed for unmanned aerial vehicles and supporting LEO constellations like Telesat and Amazon's Project Kuiper, was introduced during the quarter.

Peru revenue grew 8% to $17.2 million as the operation transitions from one-time construction work to recurring revenue. It's the smallest segment but it's stabilizing.

The Comtech acquisition is the real catalyst

Gilat agreed in June to acquire Comtech's Satellite & Space Communications segment for $157.5 million in cash, approximately $170 million including adjustments. The deal is on track for year-end closing, subject to regulatory approvals. It's the single most important event on Gilat's catalyst clock.

The combined entity is expected to generate more than $700 million in annual revenue — more than tripling Gilat's standalone base. Defense revenue alone is expected to more than double. The Comtech unit is 70-80% defense, 20-30% commercial, which tilts the combined revenue mix toward the higher-margin, higher-demand side. The deal will be funded through cash on hand ($159.2 million), available credit facilities, and new stock issuance.

For the valuation, this matters because it means Gilat's current multiple is being applied to a much smaller revenue base than the pro forma company will have. At $847 million market cap, you're buying a company that management expects to become a $700 million-plus revenue operation. The acquisition multiple implied by the stock price is not exorbitant.

The risks that are real

Free cash flow turned negative on a trailing-twelve-month basis at -$3.4 million. Q2 operating cash flow was -$1.9 million due to inventory buildup — management described this as a timing issue to shorten lead times for anticipated H2 deliveries. The inventory on the balance sheet sits at $65.5 million. That's a lot of product sitting in warehouses, and if demand softens, it becomes a margin drainer rather than a sales pipeline. The company says the inventory will be consumed over the next two to three quarters. I'll take that at face value but flag it as the single biggest near-term operating risk.

Currency is another headwind. The CFO explicitly warned that a stronger Israeli shekel will add $3 million to $5 million in operating expenses in the second half. That's up to 4% of the Q2 adjusted EBITDA number, enough to compress margins if the shekel keeps moving. Management says revenue growth and operating leverage will partially offset the hit. That's a claim worth stress-testing next quarter.

GAAP gross margin was flat at 30%, and non-GAAP gross margin slipped to 32% from 33% last year, attributed to a less favorable deal mix in defense and Peru. Margin compression at the gross level while operating margin expands means the company is leveraging fixed costs rather than actually pricing better. If deal mix normalizes, gross margins should recover. If it doesn't, operating leverage will eventually run out of runway.

Valuation: where the trade lives

Here's the setup that makes me change the rating:

Metric	Gilat (GILT)
Market cap	$847M
EV	$690M
EV/EBITDA (TTM)	12.9x
P/E (TTM)	28x
EV/Sales (TTM)	1.4x
Revenue growth (YoY)	39%
Full-year guidance growth	~13%

The stock trades at 12.9x enterprise value to EBITDA, or 1.4x sales. For a company growing revenue in the mid-teens percent, expanding margins, and closing a deal that triples its revenue base, those multiples are not pricing in success. They're pricing in caution.

Compare that to Viasat, which trades at a market cap of $11 billion and an EV/EBITDA of roughly 11x — but Viasat is a loss-making company on GAAP metrics and its entire thesis hinges on the Inmarsat integration working out. Gilat is smaller, more agile, and actually generating adjusted profitability today. The Comtech deal gives it a path to the scale Viasat already has.

The forward P/E of 110x is absurd on its face, but it reflects a small earnings base with analysts projecting modest near-term EPS. The TTM P/E of 28x is the more relevant measure, and it's compressing as the stock slides. The EV/EBITDA of 12.9x tells the real story: the market is charging roughly 13 years of current EBITDA for a business that management guides to grow 13% and add $700 million in revenue from a single acquisition.

The catalyst clock

Three events should move this stock in the next two quarters:

• H2 defense ramp. Management promised 40% H2-over-H1 defense growth. If deliveries on the BCATS mobile gateway and European orders flow through, Q3 results should show the inflection. If they don't, the growth story takes a hit.
• Comtech closing. Expected by year-end, subject to HSR and CFIUS regulatory approvals. A clean close validates the $700 million revenue thesis. A delay or regulatory snag is the main downside risk to the thesis.
• Boeing certification. First-unit Sidewinder deliveries in Q4 would confirm the in-flight connectivity ramp is real and not just a pipeline narrative.

What would change my mind

I'd downgrade this position if defense H2 revenue fails to deliver the promised 40% step-up, if the Comtech deal stumbles through regulatory review, or if free cash flow doesn't normalize as the inventory turns into sales. The currency risk is also a legitimate margin threat — if shekel weakness erodes more than $5 million of operating income in H2 and revenue growth slows, the margin expansion story breaks.

But at current levels, those risks are already reflected. The stock has given up nearly half its 52-week range. The valuation multiple has done the heavy lifting.

Rating: Buy. The business is growing, margins are expanding, a transformative acquisition is in the pipeline, and the EV/EBITDA multiple has compressed to a level that doesn't require perfect execution to work. The next two quarters — defense ramp and Comtech closing — are the proof points. If they deliver, there's real upside. If they don't, the 1.4x sales multiple still limits the downside for a company sitting on $159 million in cash with $700 million in pro forma revenue coming.

Monitor: H2 defense revenue growth versus the 40% guidance, Comtech regulatory timeline, free cash flow normalization, and shekel movement on operating expenses.